Pfizer announces acquisition of Wyeth, launches biopharma Web site

Pfizer, the world's largest drug maker, enhanced its pipeline with the announcement that it will acquire Wyeth for $68 billion as part of the...

Pfizer, the world's largest drug maker, enhanced its pipeline with the announcement that it will acquire Wyeth for $68 billion as part of the largest pharmaceutical deal in the last 10 years.

Branding the acquisition as the world's premier biopharmaceutical company, Pfizer and Wyeth launched a Web site, which includes podcasts and vodcasts of the companies' CEOs talking about the acquisition as well as information for patients and consumers, investors, and media.

But, the announcement also came with the news that Pfizer would cut its work force by 10% and reduce the number of manufacturing sites while it prepares to lose half of its pharmaceutical revenue stream by 2015, when the patents for Lipitor, Viagra, and other medications expires.

Here's a link to a video and two podcasts that features Pfizer's Ray Kerins and Wyeth's Gwen Fisher talking about social media, CSR, and drug safety communications at a PRWeek healthcare panel that was held in Philadelphia in November.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.